Sepik Life Sciences
Levosulpiride (75mg) + Esomeprazole (40mg)
Esmik LS 75mg/40mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Esmik LS 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole. It works by relieving the symptoms of acid reflux and neutralizing the acid production in the stomach to prevent discomfort. It is a well-tolerated medicine and provides relief for a long time.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Esmik LS 75mg/40mg Capsule SR is to be taken empty stomach.
Esmik LS 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
Take it one hour before the meal preferably in the morning Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away Do not consume alcohol while taking Esmik LS 75mg/40mg Capsule SR Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements
Store this medicine in its original container, tightly closed. Follow the storage directions specified on the pack or label. Dispose of unused medication to prevent consumption by children, pets, and other individuals.
Take Esmik LS 75mg/40mg Capsule SR exactly as prescribed by your healthcare provider. The recommended dosage is one capsule daily on an empty stomach.
Individuals with known allergies to any of the components or excipients of this medication should avoid using Esmik LS 75mg/40mg Capsule SR.
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) after taking Esmik LS 75mg/40mg Capsule SR. If you experience dizziness, it's best to rest and resume medication only when you feel better.
Some studies have shown that treatment with Esmik LS 75mg/40mg Capsule SR may increase the risk of hip, wrist, or spine fractures in individuals with osteoporosis. This effect is primarily observed in those taking high doses and for extended periods (a year or more).